Nathan’s Famous, Inc. (NASDAQ:NATH - Get Rating) was the recipient of a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 15,000 shares, a drop of 15.7% from the September 15th total of 17,800 shares. Based on an average daily tradi…
PatchShares of NETSTREIT Corp. (NYSE:NTST - Get Rating) have been given an average rating of “Buy” by the six ratings firms that are covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. Th
PatchSouth Korea’s finance minister said the government will scrap taxes on foreigners’ income from investments in treasury bonds and monetary stabilization bonds from Monday. Speaking to reporters late on Saturday in the United States after a meeting of Group of 20 finance ministers and central bankers…
Hundreds of people gathered in Lorton on Saturday afternoon to celebrate the grand opening of a community center and remodeled library.
PatchBIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer (“CDO”), effective November 1, 2022. Dr. Samuel Low, who has served as Chief Dental Officer since 2016, will be taking on a new role as Vice President, Cl…
William Blair cut shares of BTRS to a “market perform” rating in a research report on Thursday.
StreetInsider.comSmall-cap companies also reportedly expect an attractive earnings outlook next year, which could further favor relative valuation.
StreetInsider.comForm 424B2 UBS AG StreetInsider.com
StockNews.com raised Mercer International from a “hold” rating to a “buy” rating in a research note on Thursday.
StreetInsider.comGuggenheim lifted their target price on Albireo Pharma to $59.00 in a report on Thursday.
StreetInsider.comForm 424B2 MORGAN STANLEY StreetInsider.com
Bridging lender and property investment firm Tab has added two new hires to its investment and sales teams.
StreetInsider.com ...
On the ASX, the iShares S&P Global Healthcare ETF (ASX: IXJ) and Russell Investments High Dividend Australian Shares ETF (ASX: RDV) might be worth digging into in 2022.What to know about the iShar
BarronsALX Oncology Holdings Inc. (NASDAQ: ALXO), which seven different research firms follow, has been given the rating of “Moderate Buy”
BarronsPrometheus Biosciences, Inc. (NASDAQ:RXDX - Get Rating) has earned an average rating of “Buy” from the ten analysts that are presently covering the company, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month price objective among bro
BarronsStocks Analysis by Thomas Monteiro covering: S&P 500, US Small Cap 2000, iShares Core S&P 500 ETF, SPDR® S&P 500. Read Thomas Monteiro’s latest article on Investing.com
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Rating) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy
1420 WBSM...
William Blair cut shares of BTRS from an “outperform” rating to a “market perform” rating in a research note on Friday.
1420 WBSM
